Comerica Bank Sells 495,886 Shares of Option Care Health, Inc. $OPCH

Comerica Bank cut its position in Option Care Health, Inc. (NASDAQ:OPCH) by 84.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 92,594 shares of the company’s stock after selling 495,886 shares during the quarter. Comerica Bank’s holdings in Option Care Health were worth $2,950,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in OPCH. V Square Quantitative Management LLC bought a new position in Option Care Health in the fourth quarter worth about $25,000. Cornerstone Planning Group LLC raised its holdings in Option Care Health by 7,621.4% in the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock worth $30,000 after purchasing an additional 1,067 shares in the last quarter. Advisory Services Network LLC bought a new position in Option Care Health in the third quarter worth about $35,000. McIlrath & Eck LLC bought a new position in Option Care Health in the second quarter worth about $37,000. Finally, Caitong International Asset Management Co. Ltd bought a new position in Option Care Health in the third quarter worth about $38,000. 98.05% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

OPCH has been the subject of a number of recent research reports. Citigroup reiterated an “outperform” rating on shares of Option Care Health in a report on Tuesday, January 13th. JPMorgan Chase & Co. cut their price objective on shares of Option Care Health from $40.00 to $33.00 and set an “overweight” rating on the stock in a report on Monday. UBS Group cut their price objective on shares of Option Care Health from $45.00 to $39.00 and set a “buy” rating on the stock in a report on Friday. Wall Street Zen downgraded shares of Option Care Health from a “buy” rating to a “hold” rating in a report on Saturday, February 28th. Finally, Stephens set a $30.00 price objective on shares of Option Care Health in a report on Friday. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Option Care Health currently has an average rating of “Moderate Buy” and an average price target of $32.08.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $21.14 on Tuesday. The business’s 50 day moving average price is $29.15 and its 200 day moving average price is $30.74. The firm has a market cap of $3.32 billion, a P/E ratio of 16.39, a P/E/G ratio of 1.12 and a beta of 0.68. Option Care Health, Inc. has a 52 week low of $18.01 and a 52 week high of $36.80. The company has a quick ratio of 1.07, a current ratio of 1.64 and a debt-to-equity ratio of 0.85.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Thursday, April 30th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.37 by $0.03. The business had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.39 billion. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The business’s quarterly revenue was up 1.3% compared to the same quarter last year. During the same period in the previous year, the business posted $0.40 EPS. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. On average, sell-side analysts expect that Option Care Health, Inc. will post 1.69 earnings per share for the current year.

Insider Activity at Option Care Health

In other Option Care Health news, CEO John Charles Rademacher acquired 12,500 shares of the company’s stock in a transaction dated Monday, May 4th. The shares were acquired at an average cost of $21.18 per share, with a total value of $264,750.00. Following the acquisition, the chief executive officer directly owned 695,152 shares of the company’s stock, valued at approximately $14,723,319.36. The trade was a 1.83% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. 1.70% of the stock is owned by company insiders.

Option Care Health Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.